Edition:
United States

ChemoCentryx Inc (CCXI.OQ)

CCXI.OQ on NASDAQ Stock Exchange Global Select Market

4.54USD
26 Jul 2016
Change (% chg)

$0.09 (+2.02%)
Prev Close
$4.45
Open
$4.44
Day's High
$4.55
Day's Low
$4.44
Volume
9,213
Avg. Vol
172,067
52-wk High
$8.78
52-wk Low
$1.93

CCXI.OQ

Chart for CCXI.OQ

About

ChemoCentryx, Inc. (ChemoCentryx) is a biopharmaceutical company. The Company is focused on discovering, developing and commercializing orally-administered therapeutics to treat orphan and rare diseases, autoimmune diseases, inflammatory disorders and cancer. It targets the chemoattractant system, which is a network of... (more)

Overall

Beta: 1.44
Market Cap(Mil.): $197.09
Shares Outstanding(Mil.): 44.29
Dividend: --
Yield (%): --

Financials

  CCXI.OQ Industry Sector
P/E (TTM): -- 36.91 37.71
EPS (TTM): -1.15 -- --
ROI: -63.35 15.22 14.43
ROE: -63.48 16.27 15.61

BRIEF-Chemocentryx reports Q2 loss of $0.28 per share

* Agreement to commercialize orally administered complement 5a receptor inhibitor CCX168 in Europe and certain other markets

May 10 2016

BRIEF-Chemocentryx receives FDA orphan products development grant

* Receives FDA orphan products development grant for orally administered complement 5A receptor inhibitor CCX168 for treatment of anca-associated vasculitis

Apr 28 2016

BRIEF-Chemocentryx files for mixed shelf of up to $150 mln

* Files for mixed shelf of up to $150 million - SEC filing Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Apr 13 2016

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $125.37 +0.48
GlaxoSmithKline plc (GSK.L) 1,670.00p +13.00
Merck & Co., Inc. (MRK.N) $58.46 -0.10
Abbott Laboratories (ABT.N) $43.45 +0.04
AstraZeneca plc (AZN.L) 4,644.98p -8.50
Pfizer Inc. (PFE.N) $36.82 +0.04
Teva Pharmaceutical Industries Limited (TEVA.TA) 20,840.00₪ -90.00
Biogen Inc (BIIB.OQ) $288.95 +1.60
Novartis AG (NOVN.S) CHF82.50 +0.30
Amgen, Inc. (AMGN.OQ) $167.63 +1.07

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Ford Investor Services, Inc.
$12.00
Provider : Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.